|
Market Closed -
Nasdaq
06:00:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 784.85 USD | -0.58% |
|
+0.43% | +1.68% |
| Market Cap | 78.37B 68.34B 64.53B 58.6B 110B 7,520B 110B 773B 298B 3,823B 294B 288B 12,302B | P/E 2026 * |
18.2x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 71.2B 62.09B 58.62B 53.23B 99.74B 6,832B 100B 702B 271B 3,473B 267B 262B 11,176B | EV / Sales 2026 * |
4.21x | EV / Sales 2027 * | 3.7x |
| Free-Float |
71.06% | Yield 2026 * |
0.5% | Yield 2027 * | 0.56% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.58% | ||
| 1 week | +0.43% | ||
| Current month | -1.78% | ||
| 1 month | -3.13% | ||
| 3 months | +28.68% | ||
| 6 months | +5.47% | ||
| Current year | +1.68% |
| 1 week | 769.57 |  | 798.84 |
| 1 month | 769.57 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | +0.43% | +31.09% | -4.81% | 78.35B | |
| -2.55% | +6.99% | +505.27% | +47.92% | 61.52B | |
| -1.11% | +5.08% | -11.47% | -33.91% | 59.78B | |
| +0.14% | -1.20% | -11.64% | +24.21% | 46.53B | |
| -0.24% | +1.22% | +2.26% | +151.03% | 45.5B | |
| -1.62% | -0.76% | +49.85% | -14.92% | 31.84B | |
| -1.81% | +3.16% | +45.71% | +110.57% | 25.4B | |
| +0.47% | +3.26% | -0.77% | +142.41% | 21.43B | |
| +0.27% | +1.96% | +62.19% | +102.81% | 15.77B | |
| -1.04% | -8.05% | +24.90% | +133.39% | 13.02B | |
| Average | -0.81% | +1.17% | +69.74% | +65.87% | 39.92B | |
| Weighted average by Cap. | -0.93% | +2.01% | +91.28% | +43.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.93B 14.76B 13.94B 12.66B 23.71B 1,624B 23.81B 167B 64.42B 826B 63.58B 62.17B 2,657B | 18.48B 16.12B 15.22B 13.82B 25.89B 1,774B 26B 182B 70.35B 902B 69.43B 67.89B 2,901B |
| Net income | 4.77B 4.16B 3.93B 3.57B 6.69B 458B 6.71B 47.08B 18.17B 233B 17.93B 17.53B 749B | 5.45B 4.75B 4.48B 4.07B 7.63B 523B 7.66B 53.71B 20.73B 266B 20.46B 20B 855B |
| Net Debt | -7.17B -6.25B -5.91B -5.36B -10.05B -688B -10.09B -70.74B -27.3B -350B -26.94B -26.34B -1,126B | -10.05B -8.77B -8.28B -7.52B -14.09B -965B -14.14B -99.17B -38.27B -491B -37.77B -36.93B -1,578B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | USD 784.85 | -0.58% | 2,473,436 |
| 17/09/26 | USD 789.45 | +1.92% | 702,816 |
| 16/09/26 | USD 774.61 | +0.06% | 382,945 |
| 15/09/26 | USD 774.11 | -2.47% | 540,837 |
| 14/09/26 | USD 793.74 | +1.57% | 591,295 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
